Conference On Therapy (1954). Amer. J. Med.17, 722.
2.
DolleryC. T.Elmslie-SmithD.McMichaelJ. (1960). Bretylium tosylate in the treatment of hypertension. Lancet, 1, 296.
3.
FordR. V.DennisE.MoyerJ. H. (1955). Pharmacology of mecamylamine (Inversine). J. Lab. clin. Med., 46, 815.
4.
FreisE. D. (1955). Mecamylamine in hypertension. Lancet, 2, 977.
5.
HaringtonM.Kincaid-SmithP. (1958). Psychosis and tremor due to mecamylamine. Lancet, 1, 499.
6.
HaringtonM.Kincaid-SmithP.MilneM. D. (1958). Pharmacology and clinical use of pempidine in the treatment of hypertension. Lancet, 2, 6.
7.
LeeG. E.WraggW. R.CorneS. J.EdgeN. D.ReadingH. W. (1958). 1, 2, 2, 6, 6, pentamethylpiperidine: A new hypotensive agent. Nature (Lond.), 181, 1717.
8.
LeishmanA. W. D.MattewsH. L.SmithA. J. (1959). Guanethidine hypotensive drug with prolonged action. Lancet, 2, 1044.
9.
LowtherC. P.TurnerR. W. D. (1960). Sympathetic blockade in treatment of hypertension. Brit. med. J., 2, 1049.
10.
MaxwellR. A.MullR. P.PlummerA. J. (1959). 2- (octahydro-1-azocinyl) -ethyl -guanidine sulphate (Ciba 5864-SU) a new synthetic antihypertensive agent. Experientia (Basel), 15, 267.
11.
PageI. H.DustanH. P. (1959). A new potent antihypertensive drug 2- (octahydro-1-azocinyl) -ethyl-guanidine sulphate. Guanethidine. J. Amer. med. Ass., 170, 1265.
12.
QuenouilleM. H. (1953). Design and analysis of experiment.London: Griffin.
13.
SpinksA.YoungE. H. P. (1958). Polyalkylpiperidines: A newer series of ganglion blocking agents. Nature (Lond.), 181, 1397.
